aica ribonucleotide has been researched along with Cardiomegaly in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adrian, L; Böhm, M; Heeren, J; Laufs, U; Lenski, M; Tödter, K | 1 |
| Balligand, JL; Beauloye, C; Bertrand, L; Horman, S; Mailleux, F | 1 |
| Du, B; Gao, L; Huang, Z; Kong, L; Li, Y; Liang, C; Liu, Y; Shi, H; Tian, X; Wang, Z; Wu, L; Yao, R; Zhang, D; Zhang, Y | 1 |
| Benham, A; Entman, ML; Kaelber, JT; Kim, E; Nam, DH; Park, HK; Reineke, EL; Soibam, B; Suh, JH; Taegtmeyer, H; Taffet, GE | 1 |
| Beauloye, C; Bertrand, L; Daskalopoulos, EP; Dufeys, C; Horman, S | 1 |
| Abel, ED; Holzenberger, M; Kim, J; LeRoith, D; Litwin, SE; Sena, S; Sloan, C; Soto, J; Theobald, HA; Wayment, BE; Wende, AR | 1 |
| Choi, A; Javadov, S; Karmazyn, M; Kilić, A; Rajapurohitam, V; Zeidan, A | 1 |
| Cook, MA; Karmazyn, M; Pang, T; Rajapurohitam, V | 1 |
| Chen, BL; Dong, YG; Liu, C; Ma, YD; Meng, RS; Wang, HN; Xiong, ZJ; Zeng, JY | 1 |
| Cai, X; Chen, B; Dong, Y; Liu, G; Mai, W; Meng, R; Pei, Z; Wei, J; Zhang, A; Zhou, Y | 1 |
| Akimoto, K; Hattori, Y; Kasai, K; Matsuoka, H; Nishikimi, T | 1 |
| Chen, D; Dong, YG; Li, HL; Liu, D; Wang, D; Yang, Q; Yin, R | 1 |
1 review(s) available for aica ribonucleotide and Cardiomegaly
| Article | Year |
|---|---|
AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.
Topics: Aging; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Berberine; Cardiomegaly; Extracellular Matrix Proteins; Fibrosis; Gene Expression Regulation; Humans; Metformin; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Resveratrol; Ribonucleotides; Signal Transduction; Stilbenes; Thiazolidinediones; Wound Healing | 2016 |
11 other study(ies) available for aica ribonucleotide and Cardiomegaly
| Article | Year |
|---|---|
AMPK Prevents Palmitic Acid-Induced Apoptosis and Lipid Accumulation in Cardiomyocytes.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Apoptosis; Cardiomegaly; Cell Line; Cells, Cultured; Fatty Acids; Lipid Metabolism; Mice, Inbred C57BL; Myocytes, Cardiac; Palmitic Acid; Phosphorylation; Rats, Sprague-Dawley; Ribonucleotides | 2017 |
Studying the Role of AMPK in Cardiac Hypertrophy and Protein Synthesis.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Enzyme Activation; Enzyme Activators; Gene Expression Regulation; MAP Kinase Signaling System; Myocytes, Cardiac; NFATC Transcription Factors; Phenformin; Phosphorylation; Primary Cell Culture; Protein Biosynthesis; Rats; Ribonucleotides | 2018 |
Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Fructose-Bisphosphate Aldolase; Heart; Heart Failure; Male; Mice; Myocardium; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Ribonucleotides; Signal Transduction; Up-Regulation | 2018 |
Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Hypoglycemic Agents; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Nuclear Receptor Coactivator 2; Ribonucleotides; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2019 |
Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cell Enlargement; Cells, Cultured; Male; Mice; Mice, Knockout; Models, Cardiovascular; Myocardial Contraction; Myocytes, Cardiac; Peptide Elongation Factor 2; Physical Exertion; Proto-Oncogene Proteins c-akt; Rats; Receptor, IGF Type 1; Receptor, Insulin; Ribonucleotides; Signal Transduction; Swimming | 2008 |
Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blotting, Western; Cardiomegaly; Cells, Cultured; Chromones; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Endothelin-1; Flavonoids; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hypoglycemic Agents; Immunoprecipitation; Male; Membrane Potential, Mitochondrial; Microscopy, Confocal; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Morpholines; Myocytes, Cardiac; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Polymerase Chain Reaction; Protein Binding; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Ribonucleotides; Sodium-Hydrogen Exchangers; Voltage-Dependent Anion Channels | 2009 |
Differential AMPK phosphorylation sites associated with phenylephrine vs. antihypertrophic effects of adenosine agonists in neonatal rat ventricular myocytes.
Topics: Adenosine; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Animals, Newborn; Blotting, Western; Cardiomegaly; Cardiotonic Agents; Cardiovascular Agents; Cell Size; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Heart Ventricles; Leucine; Myocytes, Cardiac; Phenylephrine; Phosphorylation; Rats; Rats, Sprague-Dawley; Ribonucleotides | 2010 |
Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cells, Cultured; Enzyme Activation; Forkhead Transcription Factors; Gene Silencing; Muscle Proteins; Myocytes, Cardiac; Nerve Tissue Proteins; Phenylephrine; Pyrazoles; Pyrimidines; Rats; Rats, Sprague-Dawley; Ribonucleotides; RNA, Small Interfering; Signal Transduction; Transfection; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2010 |
AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Enzyme Activation; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; PPAR alpha; Rats; Rats, Sprague-Dawley; Ribonucleotides | 2011 |
Activation of AMP-activated protein kinase enhances angiotensin ii-induced proliferation in cardiac fibroblasts.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Cells, Cultured; Drug Synergism; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Multienzyme Complexes; Myocardium; Organ Size; Proline; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Ribonucleotides; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Thymidine | 2006 |
Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Animals, Newborn; Calcineurin; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Enzyme Activation; Gene Expression Regulation, Enzymologic; Hypoglycemic Agents; Male; Mitogen-Activated Protein Kinases; Multienzyme Complexes; Myocytes, Cardiac; NF-kappa B; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Ribonucleotides; Signal Transduction; Ventricular Pressure | 2007 |